FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043146153> ?p ?o ?g. }

• W2043146153 endingPage "b5606" @default.
• W2043146153 startingPage "b5606" @default.
• W2043146153 abstract "To determine the effectiveness and cost effectiveness of using information from circulating biomarkers to inform the prioritisation process of patients with stable angina awaiting coronary artery bypass graft surgery.Decision analytical model comparing four prioritisation strategies without biomarkers (no formal prioritisation, two urgency scores, and a risk score) and three strategies based on a risk score using biomarkers: a routinely assessed biomarker (estimated glomerular filtration rate), a novel biomarker (C reactive protein), or both. The order in which to perform coronary artery bypass grafting in a cohort of patients was determined by each prioritisation strategy, and mean lifetime costs and quality adjusted life years (QALYs) were compared.Swedish Coronary Angiography and Angioplasty Registry (9935 patients with stable angina awaiting coronary artery bypass grafting and then followed up for cardiovascular events after the procedure for 3.8 years), and meta-analyses of prognostic effects (relative risks) of biomarkers.The observed risk of cardiovascular events while on the waiting list for coronary artery bypass grafting was 3 per 10,000 patients per day within the first 90 days (184 events in 9935 patients). Using a cost effectiveness threshold of pound20,000- pound30,000 (euro22,000-euro33,000; $32,000-$48,000) per additional QALY, a prioritisation strategy using a risk score with estimated glomerular filtration rate was the most cost effective strategy (cost per additional QALY was < pound410 compared with the Ontario urgency score). The impact on population health of implementing this strategy was 800 QALYs per 100,000 patients at an additional cost of pound 245,000 to the National Health Service. The prioritisation strategy using a risk score with C reactive protein was associated with lower QALYs and higher costs compared with a risk score using estimated glomerular filtration rate.Evaluating the cost effectiveness of prognostic biomarkers is important even when effects at an individual level are small. Formal prioritisation of patients awaiting coronary artery bypass grafting using a routinely assessed biomarker (estimated glomerular filtration rate) along with simple, routinely collected clinical information was cost effective. Prioritisation strategies based on the prognostic information conferred by C reactive protein, which is not currently measured in this context, or a combination of C reactive protein and estimated glomerular filtration rate, is unlikely to be cost effective. The widespread practice of using only implicit or informal means of clinically ordering the waiting list may be harmful and should be replaced with formal prioritisation approaches." @default.
• W2043146153 created "2016-06-24" @default.
• W2043146153 creator A5000023013 @default.
• W2043146153 creator A5004792268 @default.
• W2043146153 creator A5004828576 @default.
• W2043146153 creator A5016300249 @default.
• W2043146153 creator A5018763661 @default.
• W2043146153 creator A5033113929 @default.
• W2043146153 creator A5041152644 @default.
• W2043146153 creator A5049679176 @default.
• W2043146153 creator A5058539268 @default.
• W2043146153 creator A5060049178 @default.
• W2043146153 creator A5061596702 @default.
• W2043146153 creator A5079795046 @default.
• W2043146153 creator A5081842404 @default.
• W2043146153 creator A5086222012 @default.
• W2043146153 creator A5087080269 @default.
• W2043146153 creator A5088464994 @default.
• W2043146153 date "2010-01-19" @default.
• W2043146153 modified "2023-10-02" @default.
• W2043146153 title "Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery" @default.
• W2043146153 cites W1966006109 @default.
• W2043146153 cites W1971428935 @default.
• W2043146153 cites W1983500792 @default.
• W2043146153 cites W1984814419 @default.
• W2043146153 cites W1994224528 @default.
• W2043146153 cites W2013307081 @default.
• W2043146153 cites W2014731893 @default.
• W2043146153 cites W2016117430 @default.
• W2043146153 cites W2026880842 @default.
• W2043146153 cites W2029652437 @default.
• W2043146153 cites W2031862935 @default.
• W2043146153 cites W2039448243 @default.
• W2043146153 cites W2051585408 @default.
• W2043146153 cites W2054106561 @default.
• W2043146153 cites W2058719728 @default.
• W2043146153 cites W2064097621 @default.
• W2043146153 cites W2065960788 @default.
• W2043146153 cites W2066319869 @default.
• W2043146153 cites W2067119513 @default.
• W2043146153 cites W2082376914 @default.
• W2043146153 cites W2083908547 @default.
• W2043146153 cites W2090957196 @default.
• W2043146153 cites W2097112083 @default.
• W2043146153 cites W2099075814 @default.
• W2043146153 cites W2108842111 @default.
• W2043146153 cites W2113822022 @default.
• W2043146153 cites W2121504382 @default.
• W2043146153 cites W2125730125 @default.
• W2043146153 cites W2127582431 @default.
• W2043146153 cites W2130383679 @default.
• W2043146153 cites W2140991303 @default.
• W2043146153 cites W2151353276 @default.
• W2043146153 cites W2152495738 @default.
• W2043146153 cites W2156202966 @default.
• W2043146153 cites W2159390189 @default.
• W2043146153 cites W2160414137 @default.
• W2043146153 cites W2163092745 @default.
• W2043146153 cites W2314684025 @default.
• W2043146153 cites W2339429909 @default.
• W2043146153 cites W2431832189 @default.
• W2043146153 cites W3150418140 @default.
• W2043146153 doi "https://doi.org/10.1136/bmj.b5606" @default.
• W2043146153 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2808469" @default.
• W2043146153 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20085988" @default.
• W2043146153 hasPublicationYear "2010" @default.
• W2043146153 type Work @default.
• W2043146153 sameAs 2043146153 @default.
• W2043146153 citedByCount "40" @default.
• W2043146153 countsByYear W20431461532012 @default.
• W2043146153 countsByYear W20431461532013 @default.
• W2043146153 countsByYear W20431461532014 @default.
• W2043146153 countsByYear W20431461532016 @default.
• W2043146153 countsByYear W20431461532017 @default.
• W2043146153 countsByYear W20431461532018 @default.
• W2043146153 countsByYear W20431461532020 @default.
• W2043146153 countsByYear W20431461532022 @default.
• W2043146153 crossrefType "journal-article" @default.
• W2043146153 hasAuthorship W2043146153A5000023013 @default.
• W2043146153 hasAuthorship W2043146153A5004792268 @default.
• W2043146153 hasAuthorship W2043146153A5004828576 @default.
• W2043146153 hasAuthorship W2043146153A5016300249 @default.
• W2043146153 hasAuthorship W2043146153A5018763661 @default.
• W2043146153 hasAuthorship W2043146153A5033113929 @default.
• W2043146153 hasAuthorship W2043146153A5041152644 @default.
• W2043146153 hasAuthorship W2043146153A5049679176 @default.
• W2043146153 hasAuthorship W2043146153A5058539268 @default.
• W2043146153 hasAuthorship W2043146153A5060049178 @default.
• W2043146153 hasAuthorship W2043146153A5061596702 @default.
• W2043146153 hasAuthorship W2043146153A5079795046 @default.
• W2043146153 hasAuthorship W2043146153A5081842404 @default.
• W2043146153 hasAuthorship W2043146153A5086222012 @default.
• W2043146153 hasAuthorship W2043146153A5087080269 @default.
• W2043146153 hasAuthorship W2043146153A5088464994 @default.
• W2043146153 hasBestOaLocation W20431461531 @default.
• W2043146153 hasConcept C112930515 @default.
• W2043146153 hasConcept C11783203 @default.
• W2043146153 hasConcept C126322002 @default.

• next